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ABSTRACT OF THESIS 
	
UTILITY OF THE CAARS VALIDITY SCALES IN IDENTIFYING FEIGNED 
ADHD, RANDOM RESPONDING, AND GENUINE ADHD IN A COLLEGE 
SAMPLE 
 
Due to increased concern about malingered self-report of symptoms of attention-
deficit/hyperactivity disorder (ADHD) in college students, there is a need for instruments 
that can detect feigning.  The present study provided further validation data for a recently 
developed validity scale for the Conners’ Adult ADHD Rating Scale (CAARS), the 
CAARS Infrequency Index (CII).  The sample consisted of 139 undergraduate students; 
21 individuals with diagnoses of ADHD, 29 individuals responding honestly, 54 
individuals responding randomly (full or half), and 35 individuals assigned to malinger.   
The CII demonstrated modest sensitivity to malingering (.31-.46) and excellent 
specificity to ADHD (.91-.95).  Sequential application of validity scales had correct 
classification rates of honest (93.1%), ADHD (81.0%), malingering (57.1%), half random 
(42.3%), and full random (92.9%).   
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Chapter 1: Introduction 
Attention-Deficit/Hyperactivity Disorder 
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental 
disorder characterized by persistent symptoms of inattention and/or 
hyperactivity/impulsivity that are abnormal relative to one’s age or developmental level 
(APA, 2013).  For adults, a predominantly inattentive presentation is diagnosed when 
five or more symptoms are present such as inability to stay on task, difficulties sustaining 
attention, seeming not to listen when spoken to, and losing materials.  A predominantly 
hyperactive/impulsive presentation is diagnosed when five or more of these symptoms 
are present such as fidgeting, excessive talking, and difficulty waiting one’s turn.  The 
combined type is diagnosed when five or more symptoms from both the inattentive and 
hyperactive/impulsive categories are present (APA, 2013).  According to the Diagnostic 
and Statistical Manual of Mental Disorders-5 (DSM-5), symptoms must persist for at 
least 6 months at a level that interferes and is impairing to one’s functioning or 
development.  Symptoms must have been present prior to age 12 and these symptoms 
must occur in more than one setting (e.g. school, work, home) (APA, 2013). 
A series of longitudinal studies in the 1980s and 1990s demonstrated that ADHD 
is not a disorder that is confined to childhood, but rather is often a chronic condition 
(Klein	& Mannuzza, 1991; Weiss & Hechtman, 1993).  Evidence has emerged that up to 
50-65% of children with ADHD continue to have symptoms well into their adult years 
(Murphy & Barkley, 1996).  This increase in awareness that symptoms of ADHD can 
persist into adulthood has led to a substantial number of adults presenting for ADHD 
evaluations (Quinn, 2003).  The estimated prevalence of adult ADHD ranges from 2.5% 
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(APA, 2013) to 4.4% (Kessler et al., 2006) in the general adult population, and 2% to 8% 
in college students (DuPaul, Weyandt, O’Dell, & Varejao, 2009).   
Impairments Associated with Adult ADHD. 
Adult ADHD is thought to cause significant impairments in social, economic, 
occupational and academic functioning (Musso & Gouvier, 2012).  For example, adults 
diagnosed with ADHD are more likely to have marital and relationship problems, fewer 
friendships, and lower socioeconomic status.  In addition, such individuals often 
experience lower occupational and academic achievement (Advokat, 2010; Spencer, 
Biederman, & Mick, 2007).  In college students, a diagnosis of ADHD is often associated 
with difficulty in adjusting to college life, poorer study habits, and lower grade point 
averages relative to their peers (Norwalk, Norvilitis, & MacLean, 2009).   
Challenges in Adult ADHD Evaluations 
Unfortunately, the accurate diagnosis of adult ADHD is challenging for a number 
of reasons.  First, DSM-5 criteria require symptom onset before the age of 12 (APA, 
2013).  However, it is difficult for some adults to retrospectively recall the time course 
and nature of their symptoms, and whether they were in fact impairing relative to their 
peers.  Second, adults seldom invite informants (e.g. parents or siblings) who have 
knowledge of their childhood history to an evaluation.  Third, lack of appropriate 
documentation of early impairments (e.g. report cards or teacher evaluations) to 
corroborate self-report also makes this task challenging (Quinn, 2003).  Fourth, several 
researchers have suggested that the DSM diagnostic criteria for ADHD are better suited 
for children, and do not adequately capture how the disorder presents in adults (Green & 
Rabiner, 2012; Kessler et al., 2006; McGough & Barkley, 2004; Murphy & Barkely, 
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1996; Weiss & Hechtmann, 1993).  For example, DSM-IV diagnostic criteria for adults 
with ADHD were derived from field trials studying only children (McGough & Barkley, 
2004).  In addition, several criteria may not be developmentally appropriate for adults, as 
clinical studies have shown that symptoms of adult ADHD are more heterogeneous and 
subtle than in children (Kessler et. al, 2006; Weiss & Hechtman, 2008).  This has led 
some researchers to suggest a reduction in the severity threshold for adults (Kessler et al., 
2006; Murphy & Barkley, 1996).  For example, a study by Murphy and Barkley (1996) 
found that only those adults reporting symptoms greater than the 99th percentile met 
criteria for ADHD.  Thus, college students may experience significantly greater ADHD 
symptomatology than their peers, yet not meet the required number of symptoms as 
established by the DSM diagnostic criteria (Murphy & Barkley, 1996).  Findings such as 
these suggested that previous diagnostic criteria may have been too restrictive and non-
representative of the clinical manifestations of ADHD in adults, and thus may have failed 
to capture a significant number of adults with the disorder (McGough & Barkley, 2004).  
While the DSM-5 has addressed some of these issues (e.g., including developmentally 
appropriate examples for adults and the reduction of the diagnostic threshold from six to 
five symptoms for individuals 17 and older; APA, 2013), these revisions have not yet 
been reflected in the assessment instruments commonly administered in the clinical 
evaluation of adult ADHD. 
Malingering  
Finally, and most important for present purposes, malingering has increasingly 
been recognized as another difficulty in the clinical evaluation of adult ADHD (Harrison, 
2006).  Malingering is defined as “ the intentional production of false or grossly 
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exaggerated physical or psychological symptoms motivated by external incentives” 
(APA, 2013, p. 726).  It has been suggested that ADHD in particular may be susceptible 
to malingering because of its complex etiology (Millichap, 2008; Thome et al., 2012), 
lack of distinct symptoms, vague diagnostic criteria, and the frequent reliance on self-
report (Fuermaier et al., 2012; Mueller et al., 2012).  While the base rates of malingering 
are hard to obtain, due in part to the fact that feigners rarely confess, it is presumed that 
the prevalence of malingering the condition rises in the context of litigation or 
compensation seeking (Zasler & Martelli, 2003).  Base rates of malingering ADHD in a 
college setting have been estimated to range from 10-20% when external incentives are 
present (Musso & Gouvier, 2012).  Even higher rates of feigned ADHD have been 
reported, with one study finding up to 48% of those presenting for an ADHD evaluation 
as feigning (Sullivan, May & Galbally, 2007).  
 Incentives for Malingering in College. 
In a college setting, there are many potential benefits of obtaining a diagnosis of 
ADHD.  Under the Americans with Disabilities Act (1990), the Individuals with 
Disabilities Education Act (1975), and Section 504 of the Rehabilitation Act (1973), 
schools are mandated to provide educational accommodation to individuals with 
disabilities (Advokat, 2010; McGough & Barkley, 2004).  Such academic 
accommodations may include extra time on tests, note takers, access to instructor notes, 
and a quiet testing environment (Sullivan et al., 2007).  Clearly these incentives provide 
reasons to believe young adults might be motivated to feign the disorder in the 
demanding and competitive environment that college creates. 
Another factor potentially precipitating the feigning of ADHD by college students 
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is an increased awareness that stimulant medications commonly prescribed to patients 
with ADHD increase attention, aid in staying awake, and alleviate distress even in 
normal, healthy adults (Rabiner et al., 2009; Sansone & Sansone, 2011; Rabiner, 2013).  
These effects are desirable to many college students who believe that these medications 
can improve anyone’s academic performance (Advokat, 2010).  Evidence has shown that 
such stimulants increase blood flow to the frontal and parietal lobes, improving attention 
and alertness (Mehta et al., 2000).  This growing awareness of the effects of 
psychostimulants on academic functioning has led to an increase in individuals feigning 
ADHD in clinical evaluations to obtain access to these medications for academic or 
recreational purposes (Green & Rabiner, 2012; Lensing et al., 2013; Rabiner, 2013).  It 
should be noted, however, that although these drugs may improve an individual’s ability 
to focus and pay attention, they do not amend all academic deficits associated with the 
disorder (Advokat, 2010). 
Perhaps even more troubling is the increased usage of stimulants for recreational 
purposes, with one study reporting the prevalence rates of the nonmedical use of 
stimulant drugs in college students ranging from 13-34% (Sansone & Sansone, 2011).  
Further, these substances are sometimes inhaled or injected, serving as an inexpensive, 
prescription alternative to cocaine, or used in conjunction with other drugs and alcohol, to 
further intensify the effects (Harrison, 2006).  According to Urban and Gao (2014), the 
illicit use of prescription stimulants such as methylphenidate (MPH) and 
psychostimulants for cognitive enhancement may come with a neuronal cost.  There is 
evidence that low doses of MPH can lead to excessive levels of dopamine and 
norepinephrine in the prefrontal cortex, resulting in adverse effects on the plasticity and 
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functioning in this brain region (Tucha et al., 2014).  This can be particularly concerning 
for college students, as during this age, the prefrontal cortex is not yet fully developed 
(Urban & Gao, 2014).  Even further, excess stimulation in the nervous system due to 
stimulant abuse can lead to other serious health risks including seizures, movement 
disorders, ischemia and respiratory failure (Ciccarone, 2011).  While more research 
regarding the effects of psychostimulants on the healthy adult brain is needed, preventing 
the misuse of these medications is clearly warranted. 
 Malingering on Self-Report Measures. 
Another challenge is that ADHD is frequently diagnosed with the combination of 
a clinical interview and self-report symptom inventories.  Unfortunately, the face validity 
of ADHD symptoms makes these measures vulnerable to faking (Suhr, Buelow, & 
Riddle, 2011), and few ADHD rating scales have validity indices to detect feigning 
(Bracken & Boatwright, 2005; Suhr et al., 2011).  Further, it is easier to fake when 
endorsing items on questionnaires as opposed to producing symptoms spontaneously 
(Frueh, Hamner, Cahill, Gold, & Hamlin, 2000).  Finally, information about ADHD 
symptoms is readily accessible (e.g. via the internet), and individuals wanting to feign the 
disorder can easily find the sources needed to do so successfully, particularly on self-
report measures. 
Several simulation studies have demonstrated that self-report measures of ADHD 
are vulnerable to feigning.  One of the first studies to examine simulated ADHD on self-
report questionnaires in college students was conducted by Quinn (2003).  She compared 
the performance of students diagnosed with ADHD, ADHD simulators and a control 
group on the ADHD Behavior Checklist.  Quinn (2003) found that college students were 
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able to successfully feign symptoms on the ADHD Behavior Checklist, with no 
statistically significant differences found between the genuine ADHD participants and 
simulators.  A similar study by Fisher and Watkins (2008) found that of the college 
students with no diagnostic history of ADHD asked to simulate the disorder, 93% of 
those who completed the College ADHD Response Evaluation (CARE) and 77% of those 
who completed the ADHD Behavior Checklist successfully malingered ADHD after only 
briefly studying the diagnostic criteria. 
Jachimowicz and Geiselman (2004) examined the performance of 80 ADHD 
simulators on the Wender Utah Rating Scale (WURS), Conners’ Adult ADHD Rating 
Scale (CAARS), Brown Adult ADHD Scale (BAAS), and the Attention Rating Scale 
(ARS).  The authors found that all four rating scales were easily faked by college students 
asked to simulate ADHD, with 65% on the WURS, 75% on the ARS, 90% on the 
CAARS, and 95% of students successfully feigning on the BAAS (Jachimowicz & 
Geiselman, 2004).  In 2010, Sollman, Ranseen, and Berry compared college students 
assigned to an ADHD simulator group, a control group, and a clinical ADHD group.  The 
ADHD simulator group was given five minutes to read data describing adult ADHD 
before completing self-report questionnaires and cognitive measures.  All participants 
completed the following self-report questionnaires: the Attention Rating Scale: Current 
and Childhood Symptoms Checklists, and the Conners’ Adult ADHD Rating Scale, Self-
Report, Long Form (CAARS-S:L).  Analyses indicated no significant differences 
between ADHD simulators and the clinical ADHD group on the CAARS-S:L or the ARS 
Current and Childhood scales.  The authors also found that the Inconsistency Index (a 
random responding scale) on the CAARS-S:L did not differentiate simulated ADHD 
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from clinical ADHD (Sollman et al., 2010). 
Harrison, Edwards, and Parker (2007) compared the performance on the CAARS 
of college students with no known impairments and students asked to simulate ADHD to 
archival data collected from 72 diagnosed cases of ADHD.  The ADHD simulators were 
given diagnostic criteria from the DSM-IV-TR.  The authors found that the ADHD 
simulator group successfully feigned symptoms on the CAARS and obtained 
significantly higher scores on most subscales compared to the ADHD and control groups 
(Harrison et al., 2007).  However, most of the elevated scores from the simulators fell 
within a credible range, so their scores would still suggest the presence of ADHD 
(Harrison et al., 2007).   
Jasinski et al., (2011) asked college students to complete the CAARS-S:L under 
one of four conditions: college controls (no diagnoses, respond honestly), clinical 
controls (ADHD, respond honestly), ADHD exaggerators (ADHD but exaggerate 
symptoms), or ADHD simulators (no diagnosis, fake ADHD).  ADHD simulators and 
exaggerators were given scenarios and information from the internet.  The authors found 
that the ADHD simulators, ADHD exaggerators, and the clinical ADHD group all 
obtained significantly higher scores than the control group on the CAARS-S:L 
Inattentive, Hyperactive/Impulsive, and Total indices.  Additionally, the ADHD 
simulators, ADHD exaggerators, and the clinical ADHD groups did not differ 
significantly (Jasinski et al., 2011).  Thus, several investigations have shown that self-
report ADHD questionnaires cannot adequately distinguish between malingered and true 
ADHD, and therefore should not be the sole measure of assessment when determining a 
diagnosis (Fisher & Watkins, 2008; Harrison, 2006; Quinn, 2003). 
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Conners’ Adult ADHD Rating Scales 
One of the most widely used self-report inventories for the assessment of adult 
ADHD is the CAARS (Conners et al., 1999).  The CAARS includes 66 items grouped on 
scales measuring inattentive, hyperactive and impulsive symptoms.  The CAARS also 
has an Inconsistency Index, which consists of several pairs of items with similar content.  
As the purpose of the Inconsistency Index is to detect random or careless responding, it 
does not identify exaggeration or fabrication of symptoms for secondary gain (Suhr et al., 
2011).  Further, the accuracy of the Inconsistency Index to detect random responding has 
not been evaluated in a published study.  Some studies have shown that individuals who 
are feigning are more likely to choose items infrequently endorsed by those who have the 
disorder (Harp et al., 2011).  Thus, malingerers are unlikely to differentiate very 
infrequent symptoms from their more common counterparts (Rogers, 2003).  However, 
the standard CAARS lacks an index that includes infrequently endorsed items.  
The multiple validity scales in the Minnesota Multiphasic Personality Inventory-
2-RF (MMPI-2-RF) may serve as a model for how the validity scales in the CAARS 
could potentially function.  The recommended stepwise approach for determining the 
validity of an MMPI-2-RF profile involves first looking at the number of omitted items, 
next determining the respondent’s consistency in answering the test questions, and finally 
assessing the degree to which the respondent may be underreporting or overreporting 
symptoms.  A recent study by Mason et al. (2013) evaluated the accuracy of the MMPI-
2-RF validity scales in detecting and differentiating honest responding, genuine 
posttraumatic stress disorder (PTSD), feigned PTSD, and random responding.  The 
authors compared MMPI-2-RF results of college students with various instruction sets to 
10	
	
archival data of veterans diagnosed with PTSD.  Results indicated that both the full 
random and half random groups obtained significantly higher scores relative to the other 
groups on the Variable Response Inconsistency Index-Revised (VRIN-r), an index 
sensitive to generic random responding.  However the VRIN-r achieved only moderate 
sensitivity (44%) in detecting partially random responding, thus indicating that this index 
is less sensitive to partially random responding.  Significantly higher scores on the 
overreporting scales were found in the full random and fake PTSD groups, followed by 
the half random groups.  These findings demonstrate that both random responding and 
feigning elevate fake bad scales (Mason et al., 2013); thus, validity scales that can 
distinguish random responding from faking are needed.  Further, these results 
demonstrate the utility of the MMPI-2-RF validity scales operating as a group in 
distinguishing random responding and faking bad from honest responding.  A similar 
stepwise approach, as described above, could be used with the validity indices in the 
CAARS, provided both a random responding and infrequency index were available. 
CAARS Infrequency Index. 
Recognizing the need for an index composed of items infrequently endorsed by 
ADHD patients on the CAARS, Suhr et al. (2011) developed the CAARS Infrequency 
Index (CII).  During the development stage, the authors examined CAARS responses 
from 71 individuals who had received a diagnosis of ADHD (ADHD group), 147 
individuals who denied having ever been diagnosed with ADHD, but were currently 
diagnosed with/receiving treatment for a psychological condition and or/ scored in the 
moderately severe range on a self-report depression scale (Psychological Control group), 
and 955 individuals who reported no prior diagnosis of ADHD and minimal to no 
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symptoms of depression on the CAARS.  The authors identified 12 items that were 
endorsed as occurring “pretty much, often” to “very much, very frequently” by less than 
10% of the total sample.  The authors then summed the scores of these 12 items (each 
scored 0-3 points), creating a scale ranging from 0-36.  They found that a scores of 20 or 
less occurred in 90.1% of the ADHD group, 94.6% of the psychological group and 99.5% 
of the normal control group (Suhr et al., 2011).  Thus, a cutoff score of 21 occurred 
infrequently in all three groups and produced greater than 90% specificity.  The authors 
then validated the CII in college students undergoing evaluation for ADHD whom were 
divided into four groups: those who failed a test of feigning, Word Memory Test (WMT) 
(n = 29), individuals diagnosed with ADHD (n = 19), individuals with a psychological 
condition (n = 43), and a control group (n = 33).  Preliminary findings indicated excellent 
specificity (> 90%) and sensitivity values ranging from 30-80% for the CII in detecting 
feigned ADHD, however further research on this index is needed (Suhr et al., 2011). 
Purpose of the Present Study 
As reviewed above, it is clear that there is a need to detect feigning in the 
assessment of adult ADHD.  While the CII shows promise for the detection of 
overreporting on the CAARS, further validation is necessary before clinical application.  
The present study attempted to replicate the results found by Suhr et al. (2011), and tested 
the utility of the CII, a feigning scale built on rare responses, and the Inconsistency Index 
a random responding scale.  This study utilized a simulation design, examining 
differences between individuals diagnosed with ADHD, individuals asked to respond 
honestly (honest), individuals asked to respond randomly (full or half) and individuals 
asked to feign ADHD (ADHD simulators) on the CAARS.  Additionally, the sensitivity 
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and specificity of the CII to feigning were evaluated.  The ability of the CAARS validity 
scales for discriminating random responding from faking bad was evaluated with the 
inclusion of random responding conditions.  
The hypotheses of this study included the following: 1) the MAL (normal 
individuals responding under malingering instructions) group would self-report 
significantly more ADHD related symptoms on the CAARS clinical scales than the 
ADHD (individuals with ADHD responding under standard instructions), HON (normal 
individuals responding under standard instructions), FR (normal individuals responding 
completely randomly) and HR (normal individuals responding partially randomly) 
groups; 2) the MAL group would be within normal limits on the Inconsistency Index; 3) 
the MAL group would obtain a significantly higher raw score on the CII than the ADHD, 
HON, FR and HR groups; 4) the FR and HR groups would have moderate to high 
elevations on the CAARS clinical scales; 5) the FR and HR groups would highly elevate 
the Inconsistency Index relative to the other groups, followed by the MAL group; 6) the 
FR and HR groups would have moderate elevations on the CII.  
Chapter 2: Methods 
Participants 
 The present study included 139 undergraduate students at the University of 
Kentucky: 21 participants with ADHD diagnoses and 118 nonclinical participants.  
Twenty-nine of the non-clinical participants were randomly assigned to an honest 
condition (HON) and served as a manipulation check for the assessment protocol.  
Undergraduates were recruited using the University of Kentucky undergraduate 
psychology subject pool through a mass administered screening questionnaire.  An 
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ADHD screening form was included in the mass screening questionnaire to identify and 
recruit ADHD and non-ADHD individuals (see Appendix A).   Additionally, a flyer (see 
Appendix B) was posted in Kastle Hall (the Department of Psychology building), the 
Jesse G. Harris Psychological Services Center, and the University of Kentucky Office of 
Disabilities to recruit additional participants with ADHD.		Subject pool participants 
received one research credit as compensation for participating in the study.  Participants 
who were randomly assigned to the feigning group received one research credit and an 
additional $25 as an incentive for successful feigning.  Individuals in the ADHD group 
who responded to the posted fliers also received one research credit, or if clinical 
participants did not need research credit, they were compensated with $25 upon 
completion of the test battery. 
 The clinical subsample (ADHD) included 21 individuals with a verifiable 
diagnosis of ADHD.  No medical records were obtained; rather, the diagnosis of ADHD 
was verified via phone screening and individuals had to have received the diagnosis prior 
to age 12.  Additionally, the phone screening was used to establish that the diagnoses 
were received from a mental health professional and not based solely on self-reported 
symptoms and/or a brief consultation.  Participants were excluded if they reported any 
comorbid conditions that might interfere with attention/concentration, such as diagnosed 
or suspected psychiatric disorders, neurological disorders, intellectual disabilities, or a 
history of significant brain injury.   
 The nonclinical participants were also recruited from the subject pool and 
randomly assigned to one of four groups; 29 nonclinical participants were randomly 
assigned to an honest condition (HON), 35 to a feigning group (MAL), 28 to a 
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completely random group (FR), and 26 to a partially random group (HR).  Individuals 
with a history of ADHD, neurological disorders, or psychiatric disorders were excluded 
from these nonclinical groups.  In addition, individuals were excluded from the study if 
they were younger than 18 or older than 30.  Informed consent was obtained directly 
from the participant.  Demographic characteristics of the sample (e.g. age, gender, race) 
approximated that of the larger undergraduate population at the University of Kentucky.  
Measures 
 Pre-test measures.  The following pre-test materials were utilized in this study: 
an ADHD screening measure, a brief phone interview, informed consent forms, and a 
demographics questionnaire.  As noted earlier, the screening measure (see Appendix A) 
was included in the Psychology subject pool mass screening questionnaire to recruit 
participants.  It asked students to indicate whether they had been diagnosed with ADHD 
and/or additional psychiatric or neurological disorders.  The form also asked additional 
information related to ADHD (diagnostic age, medications, accommodations, familial 
diagnoses etc.).  The phone interview (see Appendix C) was used to determine whether 
individuals wished to participate in the study, whether they met inclusion and exclusion 
criteria, and which group assignment was most appropriate given the individual’s medical 
history (i.e., ADHD vs. the nonclinical groups).  The informed consent form provided 
participants with information about the study, including risks and benefits of the study, 
and required the signature of the participant before beginning the study procedures.  The 
demographics questionnaire (see Appendix E) asked the participants to provide personal 
information (i.e. age, race, gender etc.) and to indicate any psychiatric diagnoses and 
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treatment.  All pre-test measures were administered under standard instructions before 
specific group instructions were given (see Appendices F, G, H, I and J). 
Test Battery.  The test battery was administered under standard instruction for 
the ADHD and HON groups and the remaining groups were given altered instructions 
specific to their group.  Thus, the MAL group was under instruction to malinger and the 
random responding groups (HR and FR) were instructed to respond randomly as 
described in the Procedure. 
Conners’ Adult ADHD Rating Scale, Self-Report, Long Form (CAARS; 
Conners, Erhardt, & Sparrow, 1999). The CAARS is a 66-item self-report inventory of 
common symptoms of ADHD.  Items on the long form of the CAARS are grouped on 
four factor-derived scales (Inattention/Memory Problems, Hyperactivity/Restlessness, 
Impulsivity/Emotional Lability, and Problems with Self-Concept), three DSM-IV scales 
(Inattentive, Hyperactive-Impulsive, and Total ADHD Symptoms), and an ADHD index 
containing items that best discriminate between ADHD and nonclinical individuals.  The 
CAARS has demonstrated strong one-month test-retest reliabilities (r = 0.80-0.91; 
Conners et al., 1999) and acceptable internal consistency (α = 0.64-0.89 for 18-29 year 
olds).  As previously mentioned, although the CAARS contains a validity scale, the 
Inconsistency Index, it is a random responding scale, thus it does not identify 
exaggeration or feigning of ADHD. 
Post-test measures.  As noted earlier, all post-test measures were administered 
under standard instruction to all participants.  Post-test measures, also under standard 
instruction, included debriefing forms for all groups elaborating on the nature of the study 
and the necessary deception regarding the monetary incentive for the feigning group (see 
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Appendices O, P, and Q).  A post-test questionnaire was administered and asked the 
participants to reiterate their instructions and indicate on a 5-point Likert scale how well 
they understood their instructions, to what degree they were able to follow them, and the 
amount of effort they put forth during testing (see Appendix M).  A score of 1 (“Not at 
All”) indicated poor understanding, ability to follow instructions, and effort, whereas a 
score of 5 (“Very”) indicated excellent understanding, ability and effort.  An additional 
post-test questionnaire (see Appendix N) was administered to all groups to identify how 
many questions they were unable to pay attention to (none to all), resulting in random 
responding.  Participants also estimated the exact number of questions they responded to 
randomly and the length of time taken to complete the test (Berry et al., 1992).  Results 
were used to exclude subjects with random responding during supposedly valid 
responding.  Permission forms for data usage and contact for future research were also 
employed (see Appendices R and S).  Payment receipts were utilized for individuals in 
the MAL group and for individuals in the clinical group who received monetary 
compensation instead of research credits for their participation (see Appendices T and U).   
Procedure 
 The participants were primarily recruited from the psychology subject pool/mass 
screening session, based on their responses to the questionnaire noted earlier.  Potential 
participants were then contacted by telephone by the principal investigator.  Phone 
interviews were conducted to determine whether or not an individual met the inclusion 
criteria for the study.  Individuals who met the inclusion criteria for the groups were 
asked to participate in the study, and individuals who did not meet criteria were thanked 
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for their time.  All participants received a reminder email and phone call approximately 
24 hours before their scheduled testing time.   
 Subject pool participants received one research credit for their participation in the 
study.  Participants in the MAL group were compensated with $25 in addition to the one 
research credit upon completion of the test battery.  The monetary incentive was initially 
presented to participants as a conditional reward for successfully faking ADHD on the 
questionnaire; however, all participants in the MAL group received this compensation.  
Participants recruited for the ADHD group were also compensated with one research 
credit.  As noted earlier, if clinical participants were not in need of research credits, they 
were compensated with $25. 
The study utilized a simulation design and participants were tested in small 
groups.  At the time of assessment, the researcher greeted the participants, obtained 
informed consent, and gave a short demographic questionnaire.  Participants were then 
given a brief description of the study before being presented with instructions specific to 
their group.  Both the ADHD and HON groups were instructed to complete the CAARS 
under standard instructions, responding honestly to all questions.  The HON group served 
as a manipulation check for the assessment protocol.  
 Participants assigned to the MAL group were first given a scenario (see Appendix 
H) describing a situation where it would be to their benefit to successfully fake ADHD 
and receive a diagnosis based on their test results.  They were then presented with a 
packet of information on common symptoms of ADHD, easily accessible via the Internet 
(see Appendix K).  The packet included a description of the disorder and its symptoms as 
well as example screening questions.  Participants were allowed to study the packet as 
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long as they wished.  After the participants indicated that they felt adequately 
comfortable and familiar with the information and any questions were answered, the 
researcher administered an instruction check questionnaire that asked participants to 
reiterate their instructions, write down a few characteristics of ADHD, and describe their 
strategies for faking ADHD (see Appendix L).  The participants were then reminded to 
complete the test battery as if they were operating under the given scenario.   
 Participants in the half random responding group (HR) first received standard 
instructions to begin the CAARS, responding to all questions and answering honestly.  
Participants were then instructed to stop when they completed question 33 and asked to 
raise their hands.  At this point, the test questions were removed, the random responding 
questionnaire for the first half of the test was administered, and the following typed 
instructions were given to the participant: “Occasionally people taking psychological 
tests will become bored or annoyed at some point and decide to fill out the answer sheet 
without reading the questions.  Usually, they attempt to hide the fact that they did this.  
We are interested in whether this approach can be detected.  Please respond to the 
remaining questions without creating an obvious pattern on the answer sheet.  When you 
have finished, please raise your hand” (adapted from Berry et al., 1992) (see Appendix I).  
Participants in the full random responding group (FR) were given only the CAARS 
answer sheet and the same set of instructions given to the half random responding group, 
altered to apply to the entire test (see Appendix J).   
Following the completion of the CAARS, participants in the feigning group 
received the post-test questionnaire asking them to describe the instructions for 
completing the CAARS,	to rate their success at following these instructions, and to list 
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strategies used in answering questions in accordance with the instructions.  Those who 
could not accurately reiterate their instructions or who indicated that they did not put 
forth effort to exaggerate symptoms were not included in the data set.  Participants in this 
group were also asked to rate the desirability of the possible payment and whether this 
payment offered incentive to fake ADHD.  All participants completed the random 
responding questionnaire.  As noted previously, this was used to exclude those who gave 
random responses in a supposedly valid section.  Finally, after the completion of all 
questionnaires, participants were debriefed in a small group setting.  All participants were 
compensated as indicated above for their time, asked to refrain from discussing the study 
with other individuals, and were thanked for their participation.   
Power Analysis 
 A meta-analysis by Rogers, Sewell, Martin, and Vitacco (2003) found a large 
effect size (d = 1.90) when comparing simulators to genuine patients on the F-p, a 
validity scale in the MMPI-2 that consists of items rarely endorsed by psychiatric 
inpatients as well as normals.  A-priori power analyses indicated that a total of 45 
subjects in a 5-group design provides approximately 95% power to detect a large effect 
(alpha= 0.05).  The present study consisted of 139 subjects, well above the necessary 
sample size. 
Chapter 3: Results 
Sample Description	
 Demographic data.	
A total of 168 participants from the University of Kentucky subject pool entered 
the study.  Data from 29 participants were excluded from the analyses for various 
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reasons, detailed next.  A total of 15 participants were excluded due to endorsing 
inadequate effort on the post-test questionnaire, and 10 participants were dropped for 
indicating that they responded randomly during supposedly valid responding.  Two 
individuals were not included, because they endorsed reasons for exclusion on the 
demographics questionnaire which were not given during the telephone screening: a 
current diagnosis of anxiety, and a current diagnosis of depression and anxiety, 
respectively.  One individual was excluded due to omitting 12 questions on the CAARS, 
as the CAARS manual recommends not interpreting protocols with > 5 omissions on the 
long form.  One additional individual was excluded for not responding randomly as 
instructed according to responses to the post-test questionnaire.  	
Overall, 5 participants from the HON group, 12 participants from the MAL group, 
7 participants from the HR group, and 5 participants from the FR group were excluded 
from the analyses, resulting in the following sample sizes: HON n = 29, ADHD n = 21, 
MAL n = 35, HR n = 26, and FR n = 28.  This left a final sample of 139 individuals with 
data considered valid for the analysis, including	21 participants diagnosed with ADHD, 
and 118 participants with no history of ADHD.  Table 1 provides the sample’s 
demographic makeup by group.  The overall sample was 54.7% male with a mean age of 
18.93 years old (SD = 1.16) and a mean education of 13.65 (SD = 0.86) years completed.  
The racial/ethnic makeup of the sample was 69.1% Caucasian, 17.3% African American, 
5.0% Asian/Pacific Islander, 4.3% Hispanic Latino, and 4.3% other ethnic identities.  
Additionally, 87.8% of participants were right handed and 2.9% had repeated a grade. 
The groups did not differ significantly on these demographic variables.	
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Diagnostic data.	
Participants in the ADHD group reported receiving their diagnoses at a mean age 
of 9.30 years (SD = 3.56).  The plurality of participants (23.8%) in the ADHD group were 
diagnosed with a Predominantly Hyperactive/Impulsive presentation, 14.3% were 
diagnosed with the Predominantly Inattentive presentation, 14.3% were diagnosed with 
the Combined presentation, and 47.6% did not specify a subtype.  Approximately 14.3% 
of participants with ADHD could not recall the type of professional who gave them their 
diagnoses.  Of the remaining participants with ADHD, 57.1 % reported that they received 
their diagnosis from a family physician, 23.8% reported that they received their diagnosis 
from a psychiatrist, and 4.8% reported that they received their diagnosis from a 
psychologist.  Of the participants with ADHD, 28.6% were prescribed an amphetamine 
drug (23.8% Adderall and 4.8% Vyvanse), 23.8% were prescribed the stimulant 
Concerta, 4.8% were prescribed the non-stimulant Strattera, 4.8% were being treated with 
a combination of the above medications, 4.8% of participants reported being treated with 
medications other than those listed above, and 33.3% were not currently medicated.   
Nearly half (47.6%) of participants in the ADHD group reported receiving 
accommodations from the university.  
Group Differences on the CAARS:S-L	
CAARS: S-L Clinical Scales.	
Table 2 presents data on the CAARS: S-L clinical scales.  Significant overall 
effects at p < .001 were found for all of the CAARS: S-L clinical scales.  The overall 
pattern was for higher scores for the MAL group followed by the ADHD, FR, HR and 
HON groups for all CAARS: S-L clinical scales except Impulsivity/Emotional Lability, 
22	
	
Problems with Self-Concept, and the ADHD Index.  Table 3 presents findings from 
follow-up Tukey’s HSD contrasts (p < .05) performed on all CAARS clinical scales.  
Statistically significant differences were found between the MAL and HON groups on all 
clinical scales, suggesting that the feigning manipulation worked.  There were no 
significant differences between the MAL and ADHD groups on any clinical scales, 
consistent with past research.  These findings suggest that the individuals assigned to 
malinger were able to successfully “fake” ADHD on a self-report measure, endorsing 
self-report of ADHD symptoms statistically comparable to clinical participants 
responding honestly.  Additionally, the ADHD and FR groups did not differ significantly 
on any of the eight clinical scales.  These results show that those instructed to respond 
completely randomly can produce similar clinical scale scores relative to genuine ADHD 
participants.  On the Inattention/Memory Problems scale and the ADHD Index, the 
ADHD, MAL and FR groups were not significantly different from each other and had 
significantly higher scores relative to the other groups.  The random responding groups 
(HR and FR) only moderately elevated the clinical scales.  Overall, the HON group 
endorsed significantly fewer symptoms than all other groups on five of the eight clinical 
scales.   
CAARS: S-L Inconsistency Index.	
  Table 4 presents results from the CAARS: S-L validity scales by group.  
Significant group differences at p < .001 were found for both of the validity scales.  
Individual group comparisons on the INC using Tukey’s HSD contrasts are presented in 
Table 5.  The FR group had significantly higher scores on the INC, followed by the HR, 
MAL, ADHD, and HON groups.  Thus as expected, the full random responding condition 
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was significantly higher than the other groups on this index.  There were no statistically 
significant differences between the MAL and ADHD groups on this index.  The HR, 
MAL, and ADHD groups did not differ significantly on this scale, but had significantly 
higher scores than the HON group.  The HON and ADHD groups produced comparable 
performances on this index. 
Table 5 also provides Cohen’s d effect sizes for pairwise group contrasts on the 
validity scales.   Effect sizes were large (|d| > 0.80) when comparing the HON group vs. 
the MAL, HR, and FR groups, and small for the HON vs. ADHD comparison.  Large 
effects were also found for comparisons of the FR group vs. ADHD, MAL and HR 
groups.  A medium effect size was found when comparing the ADHD and HR groups.  
Small effect sizes were found for comparisons of the HON vs. ADHD, ADHD vs. MAL, 
and MAL vs. HR groups.   
CAARS: S-L Infrequency Index.	
Table 5 displays results from Tukey’s HSD group contrasts on the CAARS 
Infrequency Index (CII).  The MAL group differed significantly from the ADHD group, 
suggesting that those instructed to malinger have difficulty recognizing items rarely 
endorsed by individuals with ADHD.  The FR and MAL groups did not differ 
significantly and had significantly higher scores on this index than all other groups.  This 
finding demonstrates that both random responding and feigning tend to elevate fake bad 
scales. The ADHD and HR groups did not differ significantly, but produced significantly 
higher scores than the HON group.  The HON group endorsed significantly fewer 
symptoms than all remaining groups on this index.   
As seen in Table 5, Cohen’s d effect sizes revealed large effects when comparing 
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the HON group with all other groups.  Large effect sizes were also found for comparisons 
of the ADHD vs. MAL, ADHD vs. FR groups, MAL vs. HR, and HR vs. FR groups.  
Small effects were found for ADHD vs. HR and MAL vs. FR comparisons. 
Classification Accuracy of the Validity Scales 
CAARS: S-L Inconsistency Index. 
Test operating characteristics for each validity scale were evaluated by 
determining sensitivity and specificity at a given cutting score.  Table 6 presents 
operating characteristics for the Inconsistency Index (INC) for contrasts of the combined 
random responding groups (FR + HR) vs. ADHD participants.  The CAARS manual 
recommends using a cut score of  > 8 on the INC to identify random responding.  Using 
this recommended cut score on the INC demonstrated moderate sensitivity (SN = .63) to 
random responding and high specificity to clinical participants under honest instructions 
(SP = .86).  In the malingering literature, specificity values of  > .90 are considered 
adequate.  When the cut score was raised to > 9, sensitivity to random responding was 
lowered (SN = .44), however specificity increased slightly (SP = .91).   When comparing 
the random responding groups vs. the ADHD and HON groups combined (see Table 7), 
the recommended cut score (> 8) produced moderate sensitivity (SN = .63) to random 
responding and 90% specificity.  Once again, a more lenient cut score of  > 9 increased 
specificity (SP = .96)  
CAARS: S-L Infrequency Index.	
Suhr and colleagues (2011) published a recommended cut score for the CAARS 
Infrequency Index ( > 21).  Table 8 provides sensitivity, specificity and hit rate values at 
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both the recommended cut score and the cut score that achieved acceptable specificity 
(defined as > .90).  For contrasts of MAL vs. ADHD, the recommended cut score 
demonstrated excellent specificity (SP = .95), yet only 34% sensitivity to malingering 
instruction.  Using a lowered cut score of  > 18 showed slightly improved sensitivity  (SN 
= .46), while still maintaining high specificity (SP = .91).  When comparing the MAL vs. 
the ADHD, HR, and FR groups combined (see Table 9), the recommended cut score 
demonstrated modest sensitivity (SN = .34) to malingering and still maintained adequate 
specificity (SP = .89) to ADHD, HR, and FR responding.  Raising the cut score to > 22, 
produced excellent specificity (SP = .92) and modest sensitivity (SN = .31).   
Finally, to evaluate the accuracy of the CAARS validity scales when used in a 
stepwise manner at the recommended cut scores, an algorithm (see Figure 1) was 
employed to classify individuals as randomly responding, overreporting, or producing 
valid profiles.  Table 10 shows the rates and classification for each group using the 
algorithm.  Following the stepwise procedure, the validity scales demonstrated good 
accuracy at identifying both honest (93.1%) and completely random protocols (92.9%), 
and were moderately good at classifying ADHD protocols (81.0%).  The validity scales 
did not perform well at detecting half random protocols (42.3%).  Of note, sequential 
application of the validity scales flagged more malingerers as invalid as opposed to when 
using the CII alone, identifying 57.1% of fake bad protocols versus 34.3%.  
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Table 3.1: Demographic Characteristics of Participants Included in Final Analyses 
Group Descriptives Omnibus Test 
HON ADHD MAL HR FR F or χ2
n = 29 n = 21 n = 35 n = 26 n= 28 N = 139 p 
Male % 44.80 42.90 74.3 50 53.6 7.99 0.09 
Age M 18.86 18.90 19.00 19.08 18.79 0.27 0.90 
SD 0.83 0.94 1.59 1.19 0.95 
Education M 13.62 13.52 13.77 13.65 13.64 0.29 0.89 
Yr. SD 0.73 0.75 1.09 0.89 0.78 
Repeat 
Grade % 3.4 9.50 2.90 0 0 4.95 0.29 
Right-
handed % 96.6 90.50 85.70 73.1 92.9 8.27 0.82 
Ethnicity 20.48 0.20 
White % 65.50 85.70 54.30 76.90 71.40 
Black % 17.20 4.80 25.70 23.10 10.70 
Hispanic % 3.40 9.50 2.90 0.00 7.10 
Asian % 10.30 0.00 5.70 0.00 7.10 
Other % 3.40 0.00 11.4 0.00 3.60 
Note.  HON = Honest; ADHD = ADHD; MAL = Malingering; HR = Half Random; FR = 
Full Random; M = Mean; SD = Standard Deviation. 
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Table 3.4: CAARS-S:L: Validity Scales Mean Values by Group 
Group Descriptives 
Omnibus Test 
(N = 139) 
HON 
n = 29 
ADHD 
n = 21 
MAL 
n = 35 
HR 
n = 26 
FR 
n = 28 
M (SD) M (SD) M (SD) M (SD) M (SD) F p 
INC Raw 4.55 (1.55)  5.43 (2.13)  6.43 (2.40) 6.96  (2.03)  9.61 (2.59) 21.41 .000 
CII Raw 4.34 (4.42)  11.14 (5.86) 17.20 (7.32) 12.04 (3.38)  17.29 (4.97) 28.30 .000 
Note. These values reflect the performance of participants under experimental 
manipulation. CAARS- S:L = Conners’ Adult ADHD Rating Scale- Self Report: Long 
Form ; HON = Honest; ADHD = ADHD; MAL = Malingering; HR = Half Random; FR 
= Full Random; M = Mean; SD = Standard Deviation; INC Raw = Inconsistency Index 
raw score; CII Raw =  CAARS Infrequency Index raw score.
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Table 3.6: Operating Characteristics for CAARS 
Inconsistency Index  
Note. FR = Full Random; HR = Half Random; ADHD = ADHD; HON = Honest; INC = 
Inconsistency Index; SN = Sensitivity; SP = Specificity; HR = Hit rate.	
* = cut score derived from the CAARS manual.
Table 3.7: Operating Characteristics for CAARS 
Inconsistency Index  
FR + HR v. ADHD + HON 
Scale SN SP HR 
INC > 8 * .630 .900 .76 
INC > 9 .444 .960 .69 
Note. FR = Full Random; HR = Half Random; ADHD = ADHD; HON = Honest; INC = 
Inconsistency Index; SN = Sensitivity; SP = Specificity; HR = Hit rate.	
* = cut score derived from the CAARS manual.
FR + HR v. ADHD 
Scale SN SP HR 
INC > 8 * .630 .857 .69 
INC > 9 .444 .905 .73 
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Table 3.8: Operating Characteristics for CAARS 
Infrequency Index  
Note. MAL = Malingering; ADHD = ADHD; HR = Half Random; FR = Full Random; 
CII = CAARS Infrequency Index SN = Sensitivity; SP = Specificity; HR = Hit rate. 	
* = cut score derived from Suhr et al., (2011).
Table 3.9: Operating Characteristics for CAARS 
Infrequency Index 
MAL v. ADHD + HR + FR 
Scale SN SP HR 
CII > 21 * .343 .893 .69 
CII > 22 .314 .920 .73 
Note. MAL = Malingering; ADHD = ADHD; HR = Half Random; FR = Full Random; 
CII = CAARS Infrequency Index; SN = Sensitivity; SP = Specificity; HR = Hit rate. 	
* = cut score derived from Suhr et al., (2011).
MAL v. ADHD 
Scale SN SP HR 
CII > 21 * .343 .952 .57 
CII > 18 .457 .905 .63 
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Table 3.10: Group Classification Using an Algorithm for the CAARS Validity Scales Using 
Recommended Cut Scores 
Classification 
Group Random Fake Bad Valid % Correct 
Valid 
Invalid 
(Random 
or Fake) 
HON 2 0 27 93.1 6.9 
ADHD 3 1 17 81.0 19.1 
MAL 11 9 15 42.9 57.1 
HR 11 0 15 57.7 42.3 
FR 23 3 2 7.1 92.9 
Note. HON = Honest; ADHD = ADHD; MAL = Malingering; HR = Half Random; FR = Full 
Random. 
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Figure 1. Algorithm for determining classification of CAARS protocols.  Classification of 
individuals as randomly responding, faking bad, or producing a valid profile based on 
validity scales. INC= Inconsistency Index; CII = CAARS Infrequency Index. 
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Chapter 4: Discussion 
Overview of Findings 
Due to the increased concern of malingering of ADHD symptoms on college 
campuses, there remains a need for assessment instruments that can detect feigning of 
adult ADHD, particularly on self-report measures.  One tool to detect feigning on the 
CAARS is the CAARS Infrequency Index (CII), a scale recently developed by Suhr et 
al., (2011) which is composed of items rarely endorsed by ADHD patients.  The present 
study sought to validate the findings of Suhr et al., (2011), which indicated excellent 
specificity (> 90%) with sensitivity to extreme scores on the CAARS clinical scales 
ranging from 30-80%.  Further, this study attempted to add to the existing literature by 
evaluating the ability of the CAARS validity scales to distinguish between random 
responding and feigning, and by examining the classification accuracy of the validity 
scales when applied in a stepwise manner.   
As expected, the CAARS clinical scales were able to differentiate clinical 
participants from nonclinical honest participants, with clinical participants endorsing 
significantly more ADHD symptomatology.  However, contrary to the hypotheses, the 
CAARS clinical scales could not differentiate the MAL group from the ADHD group on 
any of the CAARS indices, and scores from the MAL group fell within the credible 
range.  In addition, the FR group’s scores were comparable to ADHD participants on all 
clinical scales, demonstrating that completely random protocols can produce similar 
profiles to clinical participants.  The random responding groups only moderately elevated 
the clinical scales. 
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In line with the hypothesis, the FR group had significantly higher elevations on 
the Inconsistency Index (INC) than all other groups.  Additionally, differences are 
evident when considering the effect sizes when comparing the FR group to all other 
groups (d = 1.14-2.39).  Thus, as expected the Inconsistency Index performed well in its 
ability to detect completely random protocols.   However, in contradiction to hypotheses, 
both the MAL and ADHD groups moderately elevated the INC, and these groups did not 
differ significantly from the HR group on this index.  Therefore, this scale did not 
perform as well at distinguishing partially random responding.  Additionally, there were 
no statistically significant differences between the MAL and ADHD groups, suggesting 
that participants feigning ADHD may have attempted to respond consistently. Overall, 
the INC demonstrated modest sensitivity to FR and HR responding combined (.44-.63) 
with high specificity to both ADHD (.86-.91) and ADHD and HON groups combined 
(.90-.96). 
Statistically significant differences were founded between the MAL and ADHD 
groups on the CII, suggesting that those instructed to malinger have difficulty 
recognizing items rarely endorsed by individuals with ADHD.  The present study also 
found that the MAL and FR groups did not differ significantly on the CII, contrary to 
what was originally predicted, and a small effect size (d= .01) further demonstrated the 
similarity between these groups on this index.  This finding is consistent with previous 
research that has demonstrated that both random responding and feigning tend to elevate 
fake bad scales. Lastly, it was predicted that the FR and HR groups would moderately 
elevate the CII.  Though this was true for the FR group, the HR group only modestly 
elevated the CII and produced scores statistically proportional to the ADHD group.  
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Further, a slight elevation was found in the ADHD group on the CII, however as 
demonstrated above, the CII is highly specific to ADHD.  Overall, current results 
regarding the ability of the CII to detect feigned ADHD are consistent with past work, 
with the CII demonstrating modest sensitivity to malingering (.31-.46) with high 
specificity to ADHD (.91-.95) and ADHD, HR, and FR groups combined (.89-.92). 
More novelly, this study utilized the recommended cut scores of the CAARS 
validity scales to evaluate the performance of the INC and CII working together to 
discriminate honest responding, genuine ADHD, feigned ADHD, and random 
responding.  In general, results were supportive of these validity scales used in a stepwise 
manner to classify honest responding, full random responding, and genuine ADHD.  
Unfortunately, currently available indices do not appear to be adequately sensitive to 
detecting random responding in the latter half of the test, with the present study 
identifying only 42.3% of partially random responders.  However, one notable finding 
from the present study was that the INC and CII flagged more malingerers as invalid 
when applied sequentially (57%), as opposed to when the CII operated alone (31-46%).  
Thus, utilizing the validity scales in a stepwise manner was not only generally successful 
at discriminating response sets, but also demonstrated additional accuracy in detecting 
feigning.  
Limitations  
While this study provides an important contribution to the current body of 
literature, limitations must be acknowledged.  First, all simulation studies come at the 
expense of external validity, however this type of design generally displays strong 
internal validity.  The present study made efforts to further strengthen internal validity by 
	 38	
administering instruction checks to ensure that the participants understood their roles, and 
by giving post-test questionnaires to gauge effort and perceived success.  Efforts to 
increase external validity were also employed through the use of monetary incentives and 
a realistic scenario.  However, despite these attempts to bolster external validity, it is still 
possible that these results do not fully generalize to the real world malingering of ADHD.  
A second limitation is that the researcher could only establish the credibility of the 
ADHD participants’ diagnoses to a limited extent, as medical records were not available 
for review.  However, all ADHD participants were recruited through a mass screening 
questionnaire administered to an undergraduate psychology subject pool, and the 
researchers have no reason to believe these individuals would lie about their diagnosis on 
the mass screening, as there is no incentive to do so. Further, ADHD participants were 
invited to participate in the study only if their diagnoses were made based on methods 
other than self-report alone and made prior to age 12.  Finally, small sample sizes, 
particularly in the ADHD group, are a concern. 
Conclusions 
 Although the present study demonstrated modest sensitivity in the detection of 
feigning, the fact that between 43-69% of malingerers went undetected warrants more 
research.  Self-report alone should not be used for the diagnosis as this and several other 
studies have shown that feigners can endorse ADHD symptomatology at similar levels to 
genuine clinical participants.   The present study has added to the literature by evaluating 
the accuracy of the INC to detect random responding, and by providing further validation 
of the CII in the detection of feigned ADHD on the CAARS.  Further, this study has 
demonstrated the added utility of the CAARS validity scales working together to 
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distinguish between various response sets.  Finally, if using the algorithm clinically, 
clinicians should have strong specificity and at least modest sensitivity in the detection of 
feigning on the CAARS. 
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Appendix A: Mass Screening Form 
What is your:      STUDENT ID # __________________  
AGE: ________ 
GENDER: ________  
Year in school:________ 
 
Do you have a diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD) or 
Attention Deficit Disorder (ADD)? 
YES   or  NO  
If YES, how old were you when you were diagnosed with ADHD or ADD? ___ 
 
Are you currently prescribed stimulant medication (Adderall, Ritalin, Concerta, Straterra, 
etc.) for ADHD? 
YES   or  NO  
 
Have you ever been prescribed stimulant medication (Adderall, Ritalin, Concerta, 
Straterra, etc.) for ADHD? 
YES   or  NO 
 
Are you currently receiving academic accommodations (extra test time, financial aid, 
electronic aids) as a result of having ADHD? 
YES   or  NO 
 
In school as a child, did you ever receive any special services (tutoring, special classes, 
extra time on tests) as a result of having ADHD? 
YES   or  NO  
 
Do you have a close friend or family member with ADHD? 
YES   or  NO 
 
How many people do you know who have used stimulant medications without a 
prescription (not including yourself)?  
Circle your answer:  None   1 – 2   3 – 4   5 or more 
 
 
How many people do you know who have faked or exaggerated problems to get a 
prescription for stimulant medication (not including yourself)?  
Circle your answer:  None   1 – 2   3 – 4   5 or more 
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Have you ever been evaluated and/or treated for a learning problem (not including 
ADD/ADHD) such as dyslexia, a reading disorder, or a problem with written 
language, for example? 
YES   or  NO 
 
Have you ever been diagnosed with a learning problem such as those mentioned above?  
YES   or  NO 
If YES, what diagnosed learning problem do you have? 
 
 
Have you ever received special help or accommodations within the school system 
because of a diagnosed learning problem with reading and/or writing? 
YES   or  NO  
 
Have you ever been evaluated and/or treated for anxiety? 
YES   or  NO  
 
Do you have a diagnosed anxiety disorder?  
YES   or  NO 
If YES, what diagnosed anxiety disorder do you have? 
 
Are you currently being treated for anxiety? 
YES   or  NO 
If YES, what medications are you taking for anxiety? 
 
Are you currently being treated for depression? 
YES   or  NO 
If YES, what mediations are you taking for depression? 
 
Do you have a history of:  
Brain injury?     YES   or  NO 
Hallucinations or delusions?   YES   or  NO  
Depression?     YES   or  NO 
 
Have you been diagnosed with any other psychological or psychiatric disorder?  
YES   or  NO 
IF YES, what diagnoses have you received? 
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Appendix B: Recruitment Flyer 
Attention UK Undergraduates!!! 
Do you have Attention Deficit Disorder? 
(ADD or ADHD) 
 
If so, you can get paid $25 to participate 
in a research study being conducted at 
the University of Kentucky. 
We would like to see how effective a 
questionnaire is at diagnosing ADHD in 
college students. 
please call or text for more information: 
Brittany 
(804) 317-6770 
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Appendix C: General Phone Screening Form 
General Phone Screening Form 
SAY: My name is __ and I'm calling from the Department of Psychology.  I'm 
contacting you because you completed the psychology online screening and indicated 
interest in a research study for psychology research credits. I have a 1-credit study. Do 
you still need research credits at this time? (if Yes): Great! I'd like to tell you more about 
the study, but first I will be asking some voluntary screening questions regarding mental 
health and medical history to determine if you are eligible.  Do you have time to answer 
these questions? (Y/N) If yes…As a voluntary participant, I would like to briefly review 
your rights.  All the information you provide is strictly confidential and is accessible only 
to research team members and individuals who may audit our work for integrity 
purposes.  There are no foreseen risks or benefits to participating in this study.  As a 
voluntary participant, you can choose to revoke your consent at any point.  Finally, if you 
have any questions or concerns I can provide contact information for the Office of 
Research Integrity at UK (859-257-9428 and/or 866-400-9428).  Do you have any 
questions before we begin?  
(if non-subject pool student) SAY: My name is __ and I'm calling from the Department 
of Psychology.  I'm contacting you because you expressed interest in participating in 
Brittany Walls’ paid research study on ADHD.  Is this a good time for you? (if Yes): 
Great!  I'd like to tell you more about the study, but first I will be asking some voluntary 
screening questions regarding mental health and medical history to determine if you are 
eligible.  Do you have time to answer these questions? (Y/N) If yes…As a voluntary 
participant, I would like to briefly review your rights.  All the information you provide is 
strictly confidential and is accessible only to research team members and individuals who 
may audit our work for integrity purposes.  There are no foreseen risks or benefits to 
participating in this study.  As a voluntary participant, you can choose to revoke your 
consent at any point.  Finally, if you have any questions or concerns I can provide 
contact information for the Office of Research Integrity at UK (859-257-9428 and/or 
866-400-9428).  Do you have any questions before we begin? 
 
1. How old are you?____________________________ 
If younger than 18 or older than 25, stop and thank them for their time. 
 
2.  What year are you? F So Jr Sr Other: (_____ th    semester) 
 
3.  What is your first language: ___________________ 
 
4.  This is a study about ADHD and other psychological disorders.  We have openings for 
people with and without ADHD.  Have you been ever diagnosed with ADHD?  
 Yes No 
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If yes to #5, inquire about specific diagnoses: 
_________________________________________________ 
 
6. Do you currently have a diagnosis of a learning disability (includes DSM-IV learning 
disorders; E.G. Writing Disorder [dysgraphia], Reading Disorder [dyslexia])?  
Yes  No 
If yes to #6, inquire about specific diagnoses: - 
_________________________________________________ 
7. Have you been diagnosed with any other psychological or psychiatric disorders 
(includes Bipolar Disorder, Schizophrenia, Personality Disorders, etc.)?  
Yes  No 
If yes to #7, inquire about specific diagnoses: 
__________________________________________________ 
8. Have you been diagnosed with a neurological disorder (includes things like Epilepsy, 
Tourrettes, Central Processing Disorder; If unsure, call or google)?  
Yes  No 
If yes to #8, inquire about specific diagnoses: 
__________________________________________________ 
*If yes to 6, 7, or 8, EXCLUDE  
9. Have you ever had a head injury (including minor concussions)?  Yes   No 
If yes, ask the following questions: 
-Have you had a head injury more severe than a concussion?  Yes   No 
 If yes, Exclude 
 If they are unsure, ask the following question: 
       
- Did you lose consciousness?       Yes   No 
- If yes: For how long?________  
 
- Were you hospitalized?        Yes   No 
- If yes: For how long?__________  
 
- Did you have any tests run?       Yes   No 
- If yes: Which and what did they find?__________  
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Exclude for LOC >30 min., positive brain imaging findings (indicating       
complicated mTBI), or extensive hospitalization. 
-How many past concussions have you had? __________________________ 
-When was your most recent concussion? ____________________________ 
Exclude for more than 2 previous concussions or concussion within the last 6 
months. 
If no to all of the above... 
SAY: Thank you very much for answering these questions.  Now let me tell you more 
about the study. This study involves you taking a questionnaire that is used to diagnose 
ADHD.  We are interested in whether this questionnaire can discriminate between people 
with ADHD and people without it.  It is a pencil/paper questionnaire. If you participate, 
it will take about 1 hour of your time and you will be compensated 1 research credit. 
Are you still interested in participating?             Yes   No  
If Yes: Collect contact information  If No: STOP.  Thank you for your time. 
10. First name: __________________ Phone: _________________  
11. Gender:  M  F  
12. Date/time scheduled: __________________________  
13. Group assignment: _____________________ 
14. Examiners: ________________________ 
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Appendix D: ADHD Phone Screening Form 
ADHD Phone Screening Form 
After switching from General phone screening: 
With your permission, I would like to collect information about the process you went 
through to get your diagnosis of ADHD, current medications, and other psychiatric or 
neurological disorders.  In addition, one requirement of the study is that you not take 
your stimulant medication for 12 hours before your participation, so that we can know 
how people with ADHD do without treatment.  Would you be interested in 
participating?          
Yes  No 
If Yes: I also need to further disclose to you the potential risks regarding the cessation of 
stimulant medication.  Such risks may include loss of concentration, difficulty with school 
work, fatigue, etc. Commonly prescribed stimulant medications for the treatment of 
ADHD include Adderall, Ritalin, Concerta, etc.  Common non-stimulant medications 
include Strattera, Wellbutrin, Zyban, etc. 
If you choose to participate, you should not double the next dose of your medication to 
make up for the missed one. 
If you have a history of chronic abuse of stimulant medications you should not participate 
in this study due to increased health risks. 
Would you still be interested in participating? 
If Yes: Continue with screener If No: STOP. Thank you for your time. 
 
I'd like to ask you more about the process you went through to get your diagnosis of 
ADHD. 
1. When were you diagnosed (age/grade/year?)_______________________ 
If 12 or older at the time of diagnosis, tell them that we are only collecting data from 
individuals who received their diagnoses before the age of 12.  Thank them for their 
time. 
 
2. What subtype of ADHD is your diagnosis (Inattentive, Hyperactive, Combined, Other 
Specified?_________________________________ 
3. What sort of health care professional gave you this diagnosis? ______________ 
Be sure to figure out whether it was a psychologist, psychiatrist, or just family 
physician. 
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4. Did you take any tests to get your diagnosis?    Yes No 
 (If yes): What sorts of tests 
    __ pencil / paper that asked about your symptoms  
    __ pencil / paper not asking specifically about symptoms  
    __ Computerized  
 __ Tests of other cognitive abilities, thinking, or learning  
  
5. Did your parent or guardian fill out any questionnaires?    Yes No 
6. Do you remember how long this evaluation took? (# Appts, # Hours) 
__________________________________ 
7. Was there someone who came into your school classroom to observe you? Yes  No 
-Diagnosis must be based on a minimum of self-report and parent-report measures 
or self-report and clinical interview.  Self-report only or less is not acceptable.   
-If you are unsure about the credibility of their diagnosis, finish the interview and 
tell them you will call them back for scheduling purposes.  Contact me about this. 
 
8. Do you have access to a diagnostic report or evaluation?    Yes No  
9. Are you taking medication for this right now?     Yes No  
What kind (If yes): ____________________  
How long have you been taking it:___________________ 
 
10. About how often do you skip a dose, either accidentally or on purpose? ___________ 
 
Make sure you check about whether they take it on the weekends (many people 
don’t and don’t consider this skipping). 
11. Are you receiving accommodations in any of your courses or through the university? 
          Yes  No  
If so, what types of help are you getting? ________________________________ 
Common accommodations include extra test time (ask how much extra [50%; 
100%], teacher’s notes and ppts, testing in a private room, priority registration, 
preferred seating for tests). 
12. Have you been diagnosed with anxiety disorder?    Yes  No 
If yes, exclude.  
If no, proceed to next question. 
 
13. Have you been diagnosed with a learning disability?    Yes  No 
If yes, exclude.  
If no, proceed to next question 
 
14. Have you been diagnosed with any other psychological, psychiatric, or neurological 
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disorders, or had a head injury?      
Yes  No 
If yes, which: ______________________________________________ 
-If yes to #14, get information about specific diagnoses. If their only additional 
diagnosis is depression, get additional information about type of depression 
diagnosis and current treatment. They can still participate. Also, if they have a 
history of brain injury, do not exclude for less than 3 past concussions. (see General 
Phone Screening for more info)  
-If other disorders than those indicated above, tell them we are not collecting data 
from individuals with those specific diagnoses. Thank them for their time. 
 
If no to all of the above... 
SAY: Thank you for answering these questions.  Now let me tell you more about the 
study.  This is a study about the ability of a questionnaire to properly diagnose people 
who do or do not have ADHD. The study takes about 50 minutes and you will be 
compensated with ($25 or 1 research credit and $25). This study involves you taking a 
questionnaire that is used to diagnose ADHD.  You may have taken the questionnaire 
before.  It is a pencil/paper questionnaire.  The study is conducted at Kastle Hall (ask if 
they know where it is and tell them if they don’t).  Would you be interested in 
participating?  
If Yes: Collect contact information If No: STOP. Thank you for your time. 
 
Go ahead and schedule if you can. 
15. First name__________________   Phone_____________________ 
16. Gender: M  F  
17. Date/Time Scheduled: ______________________ 
18. Group Assignment: _____________________  
19. Examiners: __________________________ 
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Appendix E: Demographics Questionnaire 
Demographics Questionnaire 
INSTRUCTIONS: Please respond to the following as best you can. You do not need to 
share your responses with the examiner. Your responses will NOT be associated with 
your name. Please put this in the envelope and seal it when done. 
Gender:   M  F  
Age: _______________  
Handedness:   R    L 
Ethnic background: 
African American   Hispanic/Latino  Native American 
Asian/Pacific Islander  Caucasian  Other _______________ 
Education:  Freshman     Sophomore     Junior     Senior     Other______________ 
Please check which apply to you. If you respond "Yes," please answer the Additional 
questions below: 
1. Color Blindness    N Y   
2. Repeated a Grade    N Y 
3. Knocked Unconscious  N Y 
  (respond for most severe occurrence)  
Length of Time: Unconscious________ Hospitalized_________ 
Age of occurrence: _________ Do you remember this happening?_______ 
4. Attention Deficit Disorder   N  Y 
Type: ___________________________  Age diagnosed:_______ 
What medication do you take for this?______________________  
Have you taken medication for this in the past 12 hours? Y / N 
5. Learning Disability    N  Y 
  Type: _____________________ Age diagnosed:________ 
6. Current Mood, Anxiety, 
 or Thought Disorder                          N Y  
           (list separately) 
           Type: ___________ Age diagnosed:____     Are you currently being treated? Y/ N 
           Type: ___________ Age diagnosed:____     Are you currently being treated? Y/ N 
           Type: ___________ Age diagnosed:____     Are you currently being treated? Y/ N 
7. Neurological or Neuro- 
degenerative Disorder                       N  Y 
           (list separately) 
           Type: ___________ Age diagnosed:____     Are you currently being treated? Y/ N 
           Type: ___________ Age diagnosed:____     Are you currently being treated? Y/ N 
 
Thank you!  Please seal this in the envelope provided. 
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Appendix F: Instructions for ADHD Group 
Instructions for ADHD Group 
Today you will complete a questionnaire much like a clinician would use to test someone 
for Attention Deficit/Hyperactivity Disorder (ADHD). You should try your hardest on 
this questionnaire and give your very best effort throughout the testing session. 
Are you comfortable with these instructions? Do you still wish to participate in the study? 
You will now be introduced to the person who will complete testing with you.  The 
examiner does not know what instructions you have been given, so please do not give it 
away! 
If you have any questions, please take the time to ask them right now. 
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Appendix G: Instructions for Honest Group 
Instructions for Honest Group 
Today you will complete a questionnaire much like a clinician would use to test someone 
for Attention Deficit/Hyperactivity Disorder (ADHD). You should try your hardest on 
this questionnaire and give your very best effort throughout the testing session. 
Are you comfortable with these instructions?  Do you still wish to participate in the 
study? 
You will now be introduced to the person who will complete testing with you. The 
examiner does not know what instructions you have been given, so please do not give it 
away! 
If you have any questions, please take the time to ask them right now. 
Answer the CAARS questions honestly.  Be sure to answer every question.  Raise your 
hand when you have finished. 
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Appendix H: Instructions for Malingering Group 
Instructions for Malingering Group 
Congratulations!  You have been selected for a chance to win $25 cash! 
Today you will complete a questionnaire much like a clinician would use to test you for 
attention deficit/hyperactive disorder (ADHD).  Normally, you would be asked to try 
your best on this questionnaire.  That is not what we want you to do today.  Instead, we 
want you to complete the questionnaire exactly how you think someone with ADHD 
would perform.  That is, you should try to take the questionnaire in such a way that you 
look like you have ADHD.  The questionnaire has scales designed to detect people who 
are faking, so be careful not to be too obvious.  If you can take the questionnaire in such a 
way that you are classified as having ADHD without the examiner knowing you are 
faking, you will receive $25 cash at the end of testing.  It will help if you imagine the 
following scenario: 
You have a friend on campus who has just been diagnosed with ADHD. She is prescribed 
a stimulant drug (like Ritalin or Adderall) that makes her concentrate better and stay 
awake more easily.  Studying becomes much easier for her and takes less time. 
Meanwhile, her grades have improved.  On top of that, the University gives her extra 
time to complete exams and other assignments because she has ADHD.  Because 
schoolwork is easier, she is able to socialize more often.  She tells you that all she had to 
do was take a few tests to receive her diagnosis.  You feel you could really use some extra 
time on exams and assignments, and it would be great to have some medication to help 
you study faster, so you decide you will try to get a diagnosis, too.  You search the 
Internet for information on ADHD, and you make an appointment for testing. 
The next few pages contain the information you might find in an internet search for 
ADHD. 
[After preparation] Are you comfortable with these instructions? Do you still wish to 
participate in the study? You will now be introduced to the person who will complete 
testing with you.  Please take the following questionnaire as if you are trying to convince 
someone that you have ADHD.  You should respond to the test items in a way that makes 
it clear that you have ADHD. The examiner who tests you will not know what 
instructions you have been given, so please do not give it away! 
Remember, if you are successful at deceiving the questionnaire without being detected by 
the examiner as faking, you will win $25! If you have any questions, please take the time 
to ask them right now. 
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Appendix I: Instructions for Half Random Group  
Instructions for Half Random Group Part 1 
Today you will complete a questionnaire much like a clinician would use to test someone 
for Attention Deficit/Hyperactivity Disorder (ADHD).  You should try your hardest on 
this questionnaire and give your very best effort throughout the testing session. 
Are you comfortable with these instructions?  Do you still wish to participate in the 
study? 
You will now be introduced to the person who will complete testing with you. The 
examiner does not know what instructions you have been given, so please do not give it 
away! 
If you have any questions, please take the time to ask them right now. 
 
Answer the CAARS questions honestly.  Be sure to answer every question.  STOP when 
you reach question 33 and raise your hand.  This question has been highlighted on the 
answer sheet to remind you when to stop.  
 
 
Instructions for Half Random Group Part 2 
Occasionally people taking psychological tests will become bored or annoyed at some 
point and decide to fill out the answer sheet without reading the questions.  Usually, they 
attempt to hide the fact that they did this.  We are interested in whether this approach can 
be detected.  Please respond to the remaining questions without creating an obvious 
pattern on the answer sheet.  When you have finished, please raise your hand. 
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Appendix J: Instructions for Full Random Group 
Instructions for Full Random Group 
Today you will complete a questionnaire much like a clinician would use to test you for 
attention deficit/hyperactive disorder (ADHD).  Normally, you would be asked to try 
your best on this questionnaire.  That is not what we want you to do today.  
 
Occasionally people taking psychological tests will become bored or annoyed at some 
point and decide to fill out the answer sheet without reading the questions.  Usually, they 
attempt to hide the fact that they did this.  We are interested in whether this approach can 
be detected.  Please respond to the questions without creating an obvious pattern on the 
answer sheet.  When you have finished, please raise your hand. 
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Appendix K: Internet Information Packet on ADHD 
Internet Information on ADHD 
The next several pages will provide you with information about ADHD that you can easily access via the 
Internet.  You will need to read the following information carefully.  Feel free to underline or write notes 
on these pages.  At the end of the Internet information, you will be asked to jot down a few symptoms or 
characteristics of people with ADHD to help you make sure the tests classify you as having ADHD. 
Website 1 
 
Address http://www.daytrana.com/?SOURCE=GOOG&KEYWORD=p 
 
WHAT ARE THE SYMPTOMS OF ADHD? 
• The most common behaviors exhibited by those who have ADHD are inattention, 
hyperactivity, and impulsivity. People with ADHD often have difficulty focusing, are    
easily distracted, have trouble staying still, and frequently are unable to control their 
impulsive behavior.  
• Because everyone shows signs of these behaviors at times, the DSM-IV-TR specifies that  
the behaviors must appear early in life (before age 7) and continue for at least six months. 
• In children, these behaviors must be more frequent or severe than in other children the    
same age. In addition, the behaviors must interfere with at least two areas of a person’s     
life, such as paying attention in school, completing homework, or making friends.  
• ADHD in adults looks much as it does in children, except that much less hyperactivity is 
present. Still, inattention and impulsivity can have a major effect on functioning at work   
and in social relationships.  People often have difficulty focusing, are easily distracted,    
have trouble staying still, and frequently are unable to control their impulsive behavior.  
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Website 2 
 
 
Address http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp 
 
Recognizing Adult ADHD 
Fidgeting, interrupting conversations, losing things, forgetting the reason for a trip             
to the grocery store – everyone acts this way once in a while. But a long and persistent   
history of restless, impulsive, or inattentive behavior may be a sign of Adult ADHD.      
This is especially true if these behaviors have existed since childhood and result in 
problems at work, home, and/or in social situations. 
If you think you may have Adult ADHD, here are several questions you may want to       
ask yourself. These are some of the questions that can help doctors and healthcare 
professionals screen for Adult ADHD. 
Ask yourself these questions and think about how long you have experienced these 
symptoms and how often they occur. If these symptoms are interfering with your      
success at home, at work or with friends, you may want to talk with your doctor or 
healthcare professional about a clinical evaluation. 
• Do you have difficulty concentrating or focusing your attention on one thing? 
• Do you often start multiple projects at the same time, but rarely finish them? 
• Do you have trouble with organization? 
• Do you procrastinate on projects that take a lot of attention to detail? 
• Do you have problems remembering appointments or obligations? 
• Do you have trouble staying seated during meetings or other activities? 
• Are you restless or fidgety? 
• Do you often lose or misplace things? 
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On the next two pages are diagnostic screening tests you find.  Please read through the 
questions.  You do not need to complete the tests. 
Website 3 
 
Address http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp 
 
Screener Test 
Many adults have been living with Adult Attention-Deficit Disorder (Adult ADHD) and  
don't recognize it. Why? Because its symptoms are often mistaken for a stressful life. If 
you've felt    this type of frustration most of your life, you may have Adult ADHD; a 
condition your doctor   can help diagnose and treat. 
 
Adult Self-Report Scale (ASRS – V1.1) Screener  
      from WHO Composite International Diagnostic Interview 
© World Health Organization 
  
 
 
How often do you have trouble wrapping up the final details of a                      
project, once the challenging parts have been done? 
◘   ◘   ◘   ◘    ◘ 
  
How often do you have difficulty getting things in order when  
you have to do a task that requires organization?  
◘   ◘   ◘   ◘    ◘ 
  
How often do you have problems remembering appointments 
or obligations?   
◘   ◘   ◘   ◘    ◘ 
  
When you have a task that requires a lot of thought, how  
often do you avoid or delay getting started? 
◘   ◘   ◘   ◘    ◘ 
  
How often do you fidget or squirm with your hands or  
your feet when you have to sit down for a long time? 
◘   ◘   ◘   ◘    ◘ 
  
How often do you feel overly active and compelled to do things,  
like you were driven by a motor?   ◘   ◘   ◘   ◘    ◘ 
 
 
 
Website 4 
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Address http://psychcentral.com/ADHDquiz.htm 
Adult ADD/ADHD Test 
Jasper/Goldberg Adult ADHD Screening Quiz 
by Larry Jasper & Ivan Goldberg  
Instructions: The 24 items below refer to how you have behaved and felt DURING MOST OF 
YOUR ADULT LIFE. If you have usually been one way and recently have changed,  your 
responses should reflect HOW YOU HAVE USUALLY BEEN. For each item, indicate  the 
extent to which it is true by checking the appropriate box next to the item.  
1. At home, work, or school, I find my mind wandering from tasks that are uninteresting or
difficult.
2. I find it difficult to read written material unless it is very interesting or very easy.
3. Especially in groups, I find it hard to stay focused on what is being said in conversations.
4. I have a quick temper... a short fuse.
5. I am irritable, and get upset by minor annoyances.
6. I say things without thinking, and later regret having said them.
7. I make quick decisions without thinking enough about their possible bad results.
8. My relationships with people are made difficult by my tendency to talk first and think later.
9. My moods have highs and lows.
10. I have trouble planning in what order to do a series of tasks or activities.
11. I easily become upset.
12. I seem to be thin skinned and many things upset me.
13. I almost always am on the go.
14. I am more comfortable when moving than when sitting still.
15. In conversations, I start to answer questions before the questions have been fully asked.
16. I usually work on more than one project at a time, and fail to finish many of them.
17. There is a lot of "static" or "chatter" in my head.
18. Even when sitting quietly, I am usually moving my hands or feet.
19. In group activities it is hard for me to wait my turn.
20. My mind gets so cluttered that it is hard for it to function.
21. My thoughts bounce around as if my mind is a pinball machine.
22. My brain feels as if it is a television set with all the channels going at once.
23. I am unable to stop daydreaming.
24. I am distressed by the disorganized way my brain works.
When you are done reviewing these materials, please use the paper to jot down 
symptoms that will help you remember how to fake on the tests you will be given. Tell the 
examiner when you are done. 
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Appendix L: Instruction Check for Malingering Group 
 
Instruction Check 
 
Please write below the instructions you have been given. The researcher will also ask you 
to verbally describe the role you have been asked to fulfill. 
 
 
 
 
 
 
 
 
Please list below several characteristics of individuals with Attention Deficit 
Hyperactivity Disorder: 
 
1. 
 
2. 
 
3. 
 
 
 
 
Please list a few strategies you will use to convince the tests that you have Attention 
Deficit Hyperactivity Disorder: 
 
1. 
 
2. 
 
3. 
 
 
 
 
 
 
If you have any questions at all, please take the time to ask them now! 
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Appendix M: Post-Test Questionnaire 
 
Post-test Questionnaire 
Please write the instructions (role) you were given at the very beginning of this study:  
 
 
 
How well did you understand these instructions given at the very beginning? 
___________________________________________________________ 
1  2  3  4  5 
Not at          Somewhat            Perfectly   
All         Understood              Well 
 
 
How hard did you try to follow the instructions or role given at the very beginning? 
___________________________________________________________ 
1  2  3  4  5 
Not at          Somewhat                Your  
All              Hard              Hardest   
        
 
How difficult was it for you to adhere to the instructions and play the role throughout the 
session?  
___________________________________________________________ 
1  2  3  4  5 
Not at           Somewhat              Very   
All            Difficult           Difficult 
 
How successful do you think you were at following those instructions or playing the role? 
___________________________________________________________ 
1  2  3  4  5 
Not at           Somewhat         Extremely   
All          Successful         Successful 
 
 
How motivating was the incentive offered for successfully playing the role? 
___________________________________________________________ 
1  2  3  4  5 
Not at           Somewhat         Extremely   
All          Motivating         Motivating 
 
What strategies did you use to make sure you followed your instructions? 
 
1. 
 
2. 
 
3. 
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Appendix N: Random Responding Questionnaire 
 
Random Responding Questionnaire 
 
1. Please circle one statement that corresponds to the proportion of test questions 
which you were unable to pay attention to and answered randomly: 
a. None of the questions 
b. A few of the questions 
c. Several of the questions 
d. Many of the questions 
e. Most of the questions 
f. Almost every question 
g. All of the questions 
 
2. Please indicate the approximate number of questions answered randomly: 
_________ 
 
3. I took ______ minutes to complete the test. 
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Appendix O: Debriefing Form for Honest Groups 
 
Explanation of Study:  Debriefing Form for Honest Groups 
 
Thank you for participating in our study!  As we told you in the beginning, the purpose of this 
study is to determine how effectively a questionnaire discriminates between individuals with and without 
ADHD.  Such information is important to accurately diagnosing students who deserve accommodations 
and need treatment for the disorder.  
 
In this study, some students were instructed to fake having ADHD, and they will be compared to 
groups of students who were asked to respond honestly, to respond randomly, or have been previously 
diagnosed with ADHD.  Thus, the independent variable is whether a person was instructed to fake, 
randomly respond, or answer honestly.  The dependent variable is how well the groups will perform on the 
questionnaire.  We hypothesize that the questionnaire will be able to detect who is faking and distinguish 
them from true responders and random responders.  The questionnaire used in this study is often used to 
detect the presence of ADHD, and now we want to see how well they are able to differentiate feigned 
ADHD from true ADHD and random responding. 
 
We ask that you do not discuss this with anyone.  If others know how the study is run, then we will 
not get the effort and motivation from participants necessary for us to determine if this questionnaire really 
works!  This is an important study that can bring the University of Kentucky much recognition if it is run 
properly, so please do not discuss what you did with anyone! 
 
Thank you again for your participation!  It would not be possible to continue psychological 
research without your goodwill and cooperation. We hope that you enjoyed this experiment.  If you would 
like to learn more about faking of disorders, please feel free to contact the primary investigator or consult 
the references below.  We expect to have the results analyzed by next summer, so feel free to contact the 
primary investigator if you are interested in the findings.  
 
 
    Brittany Walls 
    111-C Kastle Hall 
    (804) 317-6770 
 
References: 
 
Harrison, A. G., Edwards, M. J., & Parker, K. C. H. (2007). Identifiying students faking  
ADHD: Preliminary findings and strategies for detection. Archives of Clinical Neuropsychology, 
22, 577-588.  
Sollman, M. J., Ranseen, J. D., & Berry, D. T. R. (2010). Detection of feigned ADHD in  
college students. Psychological Assessment, 22 (2), 325-335.  
Sullivan, B. K., May, K., & Galbally, L. (2007). Symptom exaggeration by college students in attention-
deficit hyperactivity disorder and learning disorder assessments. Applied Neuropsychology, 14, 189-
207. 
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Appendix P: Debriefing Form for Malingering Group 
 
Explanation of the Study:  Debriefing Form for Faking Group 
 
Thank you for participating in our study!  As we told you in the beginning, the purpose of this 
study is to determine how effectively a questionnaire discriminates between individuals with and without 
ADHD.  Such information is important to accurately diagnosing students who deserve accommodations 
and need treatment for the disorder.  
 
In this study, some students were instructed to fake having ADHD, and they will be compared to 
groups of students who were asked to respond honestly, to respond randomly, or have been previously 
diagnosed with ADHD.  Thus, the independent variable is whether a person was instructed to fake, 
randomly respond, or answer honestly.  The dependent variable is how well the groups will perform on the 
questionnaire.  We hypothesize that the questionnaire will be able to detect who is faking and distinguish 
them from true responders and random responders.  The questionnaire used in this study is often used to 
detect the presence of ADHD, and now we want to see how well they are able to differentiate feigned 
ADHD from true ADHD and random responding. 
 
In order to motivate you to fulfill your role as well as you could, we offered that you would 
receive a "bonus incentive" of $25 if you followed instructions and were successful in your role.  In reality, 
everyone who received this role is given this incentive, regardless of how well they were able to fake 
ADHD.  We said it would only be earned if you were successful to make sure you were motivated and tried 
your hardest to follow your instructions.   
 
We ask that you do not discuss this with anyone.  If others know how the study is run, then we will 
not get the effort and motivation from participants necessary for us to determine if this questionnaire really 
works!  This is an important study that can bring the University of Kentucky much recognition if it is run 
properly, so please do not discuss what you did with anyone! 
 
Thank you again for your participation!  It would not be possible to continue psychological 
research without your goodwill and cooperation.  We hope that you enjoyed this experiment. If you would 
like to learn more about faking of disorders, please feel free to contact the primary investigator or consult 
the references below. We expect to have the results analyzed by next summer, so feel free to contact the 
primary investigator if you are interested in the findings.  
 
Brittany Walls 
    111-C Kastle Hall 
    (804) 317-6770 
 
References: 
 
Harrison, A. G., Edwards, M. J., & Parker, K. C. H. (2007). Identifiying students faking  
ADHD: Preliminary findings and strategies for detection. Archives of Clinical Neuropsychology, 
22, 577-588.  
Sollman, M. J., Ranseen, J. D., & Berry, D. T. R. (2010). Detection of feigned ADHD in  
college students. Psychological Assessment, 22 (2), 325-335.  
Sullivan, B. K., May, K., & Galbally, L. (2007). Symptom exaggeration by college students in attention-
deficit hyperactivity disorder and learning disorder assessments. Applied Neuropsychology, 14, 189-
207. 
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Appendix Q: Debriefing Form for Random Groups 
 
Explanation of the Study:  Debriefing Form for Random Groups 
 
Thank you for participating in our study!  As we told you in the beginning, the purpose of this 
study is to determine how effectively a questionnaire discriminates between individuals with and without 
ADHD.  Such information is important to accurately diagnosing students who deserve accommodations 
and need treatment for the disorder.  
 
In this study, some students were instructed to fake having ADHD, and they will be compared to 
groups of students who were asked to respond honestly, to respond randomly, or have been previously 
diagnosed with ADHD.  Thus, the independent variable is whether a person was instructed to fake, 
randomly respond, or answer honestly.  The dependent variable is how well the groups will perform on the 
questionnaire.  We hypothesize that the questionnaire will be able to detect who is faking and distinguish 
them from true responders and random responders.  The questionnaire used in this study is often used to 
detect the presence of ADHD, and now we want to see how well they are able to differentiate feigned 
ADHD from true ADHD and random responding. 
 
We ask that you do not discuss this with anyone.  If others know how the study is run, then we will 
not get the effort and motivation from participants necessary for us to determine if this questionnaire really 
works!  This is an important study that can bring the University of Kentucky much recognition if it is run 
properly, so please do not discuss what you did with anyone! 
 
Thank you again for your participation!  It would not be possible to continue psychological 
research without your goodwill and cooperation. We hope that you enjoyed this experiment.  If you would 
like to learn more about faking of disorders, please feel free to contact the primary investigator or consult 
the references below.  We expect to have the results analyzed by next summer, so feel free to contact the 
primary investigator if you are interested in the findings.  
 
 
    Brittany Walls 
    111-C Kastle Hall 
    (804) 317-6770 
 
References: 
 
Harrison, A. G., Edwards, M. J., & Parker, K. C. H. (2007). Identifiying students faking  
ADHD: Preliminary findings and strategies for detection. Archives of Clinical Neuropsychology, 
22, 577-588.  
Sollman, M. J., Ranseen, J. D., & Berry, D. T. R. (2010). Detection of feigned ADHD in  
college students. Psychological Assessment, 22 (2), 325-335.  
Sullivan, B. K., May, K., & Galbally, L. (2007). Symptom exaggeration by college students in attention-
deficit hyperactivity disorder and learning disorder assessments. Applied Neuropsychology, 14, 189-
207. 
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Appendix R: Permission for Use of Data Form 
Permission for Use of Data 
Because we misled you about the bonus being contingent on successfully 
feigning, we want to give you the opportunity to allow or prevent our use of your 
data.  Please complete the form according to your wish. 
If you do not wish to have your data included, please tell the examiner now. 
I   MAINTAIN CONSENT / WITHDRAW CONSENT to have my data used in 
this study. 
   (circle one) 
______________________________ 
Print Name  Date  
______________________________ 
Sign Name  
 ______________________________ 
Witness   Date 
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Appendix S: Permission to Contact for Future Research 
 
Permission to Contact for Future Research 
 
 
Would you be interested in participating in future studies about Attention Deficit-
Hyperactivity Disorder?      
 
_______Yes  _______ No 
 
 
Would you like to be contacted for future research opportunities in this research area?  
 
_______Yes  _______ No 
 
 
 
 
If so, please list: 
 
Name:________________________________ 
 
Phone #:______________________________ 
 
Email:________________________________ 
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Appendix T: Payment Receipt for Malingering Participants 
Receipt for Payment 
 
I acknowledge that I have received $25 payment for my participation in the study “Utility 
of the CAARS Validity Scales in Identifying Feigned ADHD, Random Responding and 
Genuine ADHD in a College Sample.” 
 
Name (Printed): ________________________________ 
Signature: _____________________________________ 
SS#: __________________________________________ 
Date: _________________________________________ 
Witness: _______________________________________ 
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Appendix U: Payment Receipt for Clinical Participants Not in Need of Research Credits 
 
Receipt for Payment 
 
I acknowledge that I have received $25 payment for my participation in the study “Utility 
of the CAARS Validity Scales in Identifying Feigned ADHD, Random Responding and 
Genuine ADHD in a College Sample.” 
 
Name (Printed): ________________________________ 
Signature: _____________________________________ 
SS#: __________________________________________ 
Date: _________________________________________ 
Witness: _______________________________________ 
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